Back
32
Day Range
$24.20
$26.30
52-Week Range
$24.20
$34.00
Volume
1,100
50D / 200D Avg
$26.72
/
$29.11
Prev Close
$24.20
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 43.3 | 0.3 |
| P/B | 2.5 | 3.0 |
| ROE % | 5.9 | 3.7 |
| Net Margin % | 9.6 | 3.8 |
| Rev Growth 5Y % | 28.4 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$1.48
$1.47 – $1.49
|
269.58M | 1 |
| FY2027 |
$1.36
$1.34 – $1.37
|
247.86M | 1 |
| FY2026 |
$1.22
$1.21 – $1.23
|
226.09M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-02 | N/A | $0.28 | — |
| 2025-03-11 | $0.51 | $0.12 | -77.2% |
| 2024-09-03 | N/A | $0.22 | — |
| 2024-05-21 | N/A | $0.12 | — |
| 2023-06-29 | N/A | $0.15 | — |
| 2022-12-30 | N/A | $0.11 | — |
| 2022-06-29 | N/A | $0.12 | — |
| 2021-12-30 | N/A | $0.13 | — |
Dividend History
Yield
0.01%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 20, 2026 | Apr 16, 2026 | $0.20 | 1.84% |
| Nov 28, 2025 | Dec 18, 2025 | $0.24 | 1.31% |
| Mar 21, 2025 | Apr 17, 2025 | $0.18 | 1.51% |
| Nov 29, 2024 | Dec 18, 2024 | $0.20 | 1.50% |
| Mar 21, 2024 | Apr 15, 2024 | $0.17 | 1.35% |
| Nov 23, 2023 | Dec 15, 2023 | $0.20 | 1.77% |
| Mar 23, 2023 | Apr 14, 2023 | $0.15 | 2.09% |
| Nov 24, 2022 | Dec 16, 2022 | $0.18 | 1.43% |
| Mar 24, 2022 | Apr 14, 2022 | $0.17 | 1.56% |
| Nov 25, 2021 | Dec 21, 2021 | $0.21 | 1.10% |
| Mar 18, 2021 | Apr 15, 2021 | $0.17 | 1.27% |
| Nov 19, 2020 | Dec 15, 2020 | $0.20 | 1.61% |
| Mar 19, 2020 | Apr 16, 2020 | $0.13 | 1.52% |
| Nov 28, 2019 | Dec 19, 2019 | $0.19 | 1.52% |
| Mar 14, 2019 | Apr 11, 2019 | $0.15 | 1.10% |
| Nov 08, 2018 | Dec 06, 2018 | $0.18 | 0.80% |
| Mar 29, 2018 | Apr 20, 2018 | $0.14 | 1.18% |
| Nov 09, 2017 | Dec 07, 2017 | $0.15 | 1.25% |
| Mar 30, 2017 | Apr 20, 2017 | $0.11 | 1.42% |
| Nov 10, 2016 | Dec 08, 2016 | $0.11 | 2.06% |
Key Takeaways
Revenue grew 28.44% annually over 5 years — strong growth
Earnings grew 68.02% over the past year
Debt/Equity of 0.09 — conservative balance sheet
Generating 59.41M in free cash flow
P/E of 43.27 — premium valuation
PEG of 0.82 suggests growth is underpriced
Growth
Revenue Growth (5Y)
28.44%
Revenue (1Y)8.66%
Earnings (1Y)68.02%
FCF Growth (3Y)-14.45%
Quality
Return on Equity
5.90%
ROIC5.13%
Net Margin9.56%
Op. Margin12.28%
Safety
Debt / Equity
0.09
Current Ratio0.66
Interest Coverage8.75
Valuation
P/E Ratio
43.27
Forward P/EN/A
P/B Ratio2.52
EV/EBITDA32.73
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.66% | Revenue Growth (3Y) | 8.71% |
| Earnings Growth (1Y) | 68.02% | Earnings Growth (3Y) | 45.94% |
| Revenue Growth (5Y) | 28.44% | Earnings Growth (5Y) | 11.10% |
| Profitability | |||
| Revenue (TTM) | 205.66M | Net Income (TTM) | 19.66M |
| ROE | 5.90% | ROA | 3.57% |
| Gross Margin | 87.17% | Operating Margin | 12.28% |
| Net Margin | 9.56% | Free Cash Flow (TTM) | 59.41M |
| ROIC | 5.13% | FCF Growth (3Y) | -14.45% |
| Safety | |||
| Debt / Equity | 0.09 | Current Ratio | 0.66 |
| Interest Coverage | 8.75 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 43.27 | Forward P/E | N/A |
| P/B Ratio | 2.52 | P/S Ratio | 4.14 |
| PEG Ratio | 0.82 | Forward PEG | N/A |
| EV/EBITDA | 32.73 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 6.98% | ||
| Market Cap | 850.72M | Enterprise Value | 826.46M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 205.66M | 189.27M | 174.02M | 165.54M | 75.58M |
| Net Income | 19.66M | 11.70M | 9.23M | 9.41M | 12.91M |
| EPS (Diluted) | 0.55 | 0.33 | 0.26 | 0.27 | 0.48 |
| Gross Profit | 179.27M | 162.20M | 122.71M | 103.44M | 66.71M |
| Operating Income | 25.25M | 19.73M | 19.23M | 18.13M | 13.24M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 551.06M | 543.66M | 583.33M | 574.64M | 311.88M |
| Total Liabilities | 213.50M | 215.06M | 256.02M | 240.89M | 51.60M |
| Shareholders' Equity | 337.56M | 328.59M | 327.31M | 333.75M | 260.28M |
| Total Debt | 31.65M | 40.15M | 86.55M | 115.78M | 2.20M |
| Cash & Equivalents | 55.92M | 34.59M | 78.41M | 48.51M | 235.62M |
| Current Assets | 119.59M | 93.23M | 113.96M | 87.99M | 253.60M |
| Current Liabilities | 181.11M | 148.76M | 127.38M | 78.08M | 49.41M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#786 of 1052
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026